|
|
Article: Studies Shows Device-Guided Paced Breathing Lowers Blood Pressure & Peripheral Resistance; RESPeRATE(R) Demonstrates Sustained Effect on Blood Vessels.
- Article from:
- Business Wire
- Article date:
- May 16, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK -- InterCure, Ltd., today announced new findings demonstrating the mechanism of action of its FDA-cleared hypertension treatment device, RESPeRATE. Details from four new studies will be presented at the American Society of Hypertension's 21st Annual Scientific Meeting (ASH 2006) in New York. The studies directly showed a reduction in the resistance of narrowed blood vessels to blood flow (peripheral resistance) and lower blood pressure.
The mechanism study, led by Dr. Kyung-Hoon Choe, from Wonju College of Medicine in South Korea, measured Systemic Vascular Resistance Index (SVRI) and other hemodynamic parameters, heart rate, and blood pressure of 22 ...